Insmed | INSM - Satış Gelirleri





Satış Değişiklik Tarih
BioMarin Pharmaceutical USD 875M 99M 2025-12
Cytokinetics USD 17.76M 15.83M 2025-12
DBV Technologies USD 2.77M 1.31M 2025-09
Gilead Sciences USD 7.93B 130M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 263.8M 121.8M 2025-12
Novartis USD 13.86B 498M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12